iTeos Therapeutics
ITOS
$10.60
Share price
0.28%
Change (1 day)
-21.19%
Change (1 year)
Categories
P/S ratio for iTeos Therapeutics (ITOS)
P/S ratio as of April 2024 (TTM): 30.2
According to iTeos Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 30.1657. At the end of 2023 the company had a P/S ratio of 31.1.
P/S ratio history for iTeos Therapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 31.1 | 1098.4% |
| 2022 | 2.60 | -45.5% |
| 2021 | 4.76 | |
| 2020 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |